Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi Yerleskesi

Istanbul 34098

0 studies enrolling now · 3 studies all time

What they study most

Advanced Cancer, Biliary Tract Cancer, Breast Cancer, Crohn's Disease, Metastatic Cancer, Non Small Cell Lung Cancer

Studies at this site

• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed